Shares of Calian Group Ltd. (TSE:CGY – Get Free Report) have earned an average recommendation of “Buy” from the six brokerages that are presently covering the stock, MarketBeat Ratings reports. Five research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. The average 12 month price objective among brokers that have covered the stock in the last year is C$69.67.
Several research analysts recently weighed in on CGY shares. Acumen Capital cut their price target on shares of Calian Group from C$75.00 to C$70.00 in a report on Wednesday, November 27th. CIBC cut their target price on Calian Group from C$63.00 to C$62.00 in a research note on Friday, February 14th. Finally, Ventum Financial reduced their target price on Calian Group from C$70.00 to C$68.00 in a report on Wednesday, November 27th.
Read Our Latest Analysis on Calian Group
Calian Group Price Performance
Calian Group Announces Dividend
The business also recently disclosed a quarterly dividend, which was paid on Wednesday, March 12th. Shareholders of record on Wednesday, March 12th were given a $0.28 dividend. This represents a $1.12 annualized dividend and a yield of 2.67%. The ex-dividend date of this dividend was Wednesday, February 26th. Calian Group’s dividend payout ratio is 119.93%.
Insider Activity
In other news, Director Valerie Sorbie purchased 1,700 shares of the business’s stock in a transaction dated Friday, December 27th. The stock was bought at an average price of C$48.27 per share, for a total transaction of C$82,059.00. Also, Director Lori O’neill acquired 600 shares of the firm’s stock in a transaction that occurred on Tuesday, February 18th. The stock was purchased at an average cost of C$44.75 per share, with a total value of C$26,850.00. Following the acquisition, the director now owns 600 shares in the company, valued at C$26,850. The trade was a ∞ increase in their position. Insiders purchased 3,147 shares of company stock valued at $148,588 in the last three months. Company insiders own 0.63% of the company’s stock.
About Calian Group
Calian Group Ltd operates through four segments namely Advanced Technologies, Health, Learning, and Information Technology. It generates maximum revenue from the Health segment. The company serves health, defence, security, aerospace, engineering, AgTech, and IT industries. Its Health segment includes Clinical Services; Nursing Services; Psychological Services and Medical Property Management.
Recommended Stories
- Five stocks we like better than Calian Group
- How to Most Effectively Use the MarketBeat Earnings Screener
- Rubrik Stock’s V-Bottom Reversal Signals a Major Rally Ahead
- How Can Investors Benefit From After-Hours Trading
- How Super Micro Computer Stock Is Defying the Market Sell-Off
- High Flyers: 3 Natural Gas Stocks for March 2022
- AppLovin vs. HPE: Which Tech Stock Can Bounce Back Faster?
Receive News & Ratings for Calian Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calian Group and related companies with MarketBeat.com's FREE daily email newsletter.